Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Latest filing published 03 Jun 2025 for REGENXBIO Inc.. Read the official filing
Filing timeline
BuySaleGeorge Migausky V
Insider track record
Disclosed buys
1
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-7.5%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
George Migausky V: trading record in brief
George Migausky V (senior executive) discloses dealings in 4 companies, chiefly Dyax Corp, Immunovant, Inc. and REGENXBIO Inc. In total, 27 filings cover trades dated from 7 January 2016 to 30 May 2025.
In open-market terms, that means 1 purchase worth €46k on one side and 1 sale worth €150k on the other. Netting one side against the other leaves €104k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 11 share grants and 12 option exercises.
On 3 June 2025 came the latest disclosure, a share grant in REGENXBIO Inc. The latest purchase dates back some time: it was published 1,888 days ago, on 20 August 2021. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to George Migausky V
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
7,768 shares0Common StockSEC:0001562180-25-004350:0
16,188 shares0Common StockSEC:0001764013-25-000041:0
4,790 shares0Common StockSEC:0001562180-24-004655:0
11,255 shares0Common StockSEC:0001764013-24-000063:0
4,200 shares@ US$38.7962.0% of flowCommon StockSEC:0001764013-23-000153:0
3,486 shares0Common StockSEC:0001562180-23-004892:0
12,523 shares0Common StockSEC:0001764013-23-000044:0
21,059 shares0Common StockSEC:0001764013-22-000093:0
3,010 shares0Common StockSEC:0001562180-22-004879:0
21,726 shares0Common StockSEC:0001764013-22-000019:0
7,000 shares@ US$7.6523.5% of flowCommon StockSEC:0001764013-21-000090:0
Canonical exit: 18 Nov 2021 (T+90)
751,975 sharesCommon StockSEC:0000908662-16-000437:0
15,000 sharesCommon StockSEC:0000908662-16-000437:1
42,734 sharesCommon StockSEC:0000908662-16-000404:0
87,729 sharesCommon StockSEC:0000908662-16-000404:1
50,007 sharesCommon StockSEC:0000908662-16-000404:2
91,042 sharesCommon StockSEC:0000908662-16-000404:3
39,999 sharesCommon StockSEC:0000908662-16-000404:4
15,000 sharesCommon StockSEC:0000908662-16-000404:5
62,500 sharesCommon StockSEC:0000908662-16-000404:6
142,239 sharesCommon StockSEC:0000908662-16-000390:0
12,266 sharesCommon StockSEC:0000908662-16-000381:0
37,271 sharesCommon StockSEC:0000908662-16-000381:1
47,761 sharesCommon StockSEC:0000908662-16-000381:2
52,077 sharesCommon StockSEC:0000908662-16-000381:3
25 of 25 declarations
